MARKET

TLGT

TLGT

Teligent Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8343
-0.2457
-22.75%
Opening 15:41 09/23 EDT
OPEN
1.030
PREV CLOSE
1.080
HIGH
1.030
LOW
0.8000
VOLUME
793.95K
TURNOVER
--
52 WEEK HIGH
10.01
52 WEEK LOW
0.8000
MARKET CAP
4.50M
P/E (TTM)
-0.0847
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Teligent CFO departs, interim appointed
Teligent (TLGT) CFO Damian Finio will leave the company to pursue another career opportunity, effective September 14.Mr. Finio, will serve as interim CFO while the company conducts a search for a permanent
Seekingalpha · 6d ago
Immunomedics, Cassava Sciences leads gainers pack, Nano-X Imaging, Teligent among major losers
Gainers: Immunomedics (IMMU) +101%, Cassava Sciences, (SAVA) +78%, Vaxart (VXRT) +28%, Mersana Therapeutics (MRSN) +17%, Venus Concept (VERO) +15%.Losers: Nano-X Imaging (NNOX) -14%, Teligent (TLGT) -12%, Mallinckrodt (MNK) -12%, Kala Pharmaceuticals (KALA) -12%, Co-Diagnostics (CODX) -11%.
Seekingalpha · 09/14 15:06
The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 3)
Benzinga · 09/04 11:28
Odonate Therapeutics leads healthcare gainers on equity offering, Pro-Dex and Rhythm Pharmaceuticals follow, Oncternal Therapeutics, Teligent and Stereotaxis among major losers
Gainers: Odonate Therapeutics (ODT) +22%, Pro-Dex (PDEX) +19%, Rhythm Pharmaceuticals (RYTM) +19%, Addex Therapeutics (ADDXF) +17%, Forte Biosciences (FBRX) +16%.Losers: Oncternal Therapeutics (ONCT) -15%, Teligent (TLGT) -9%, Stereotaxis (STXS) -7%, Viking Therapeutics (VKTX) -7%, VBI Vaccines (VBIV) -6%.
Seekingalpha · 08/28 15:01
INO, SRNE among premarket losers
Onconova Therapeutics (NASDAQ:ONTX) -71% after announcing topline results from Phase 3 INSPIRE trial. Northern Dynasty Minerals (NYSEMKT:NAK) -34% after Th
Seeking Alpha - Article · 08/24 12:27
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO
  Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 20)
Benzinga · 08/21 11:43
IBIO, GEVO, OTRK and BLNK among midday movers
Gainers: Gevo (GEVO) +198%.OpGen (OPGN) +35%.FinVolution (FINV) +22%.AutoWeb (AUTO) +23%.Fathom Holdings (FTHM) +16%..Flux Power (FLUX) +16%.Ontrak (OTRK) +16%.CureVac (CVAC) +16%.China Liberal Education (CLEU) +15%Flotek Industries (FTK) +15%.Losers: Sypris Solutions (SYPR) -31%.Blink Charging (BLNK) -27%.Opera (OPRA) -21%.Teligent
Seekingalpha · 08/20 16:39
OpGen leads healthcare gainers; iBio and Can-Fite BioPharma among losers
Gainers: OpGen (OPGN) +28%. Kazia Therapeutics (KZIA) +14%. CureVac (CVAC) +14%. Ontrak (OTRK) +13%. Zosano Pharma (ZSAN) +12%.Losers: Teligent (TLGT) -18%. iBio (IBIO) -13%. Artelo Biosciences (ARTL) -11%. Can-Fite BioPharma (CANF) -9%. Allied Healthcare Products (AHPI)
Seekingalpha · 08/20 15:02
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TLGT. Analyze the recent business situations of Teligent Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TLGT stock price target is 20.00 with a high estimate of 20.00 and a low estimate of 20.00.
EPS
Institutional Holdings
Institutions: 74
Institutional Holdings: 14.90M
% Owned: 276.40%
Shares Outstanding: 5.39M
TypeInstitutionsShares
Increased
4
13.68K
New
28
-130.48K
Decreased
7
135.90K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.43%
Pharmaceuticals & Medical Research
-1.06%
Key Executives
Chairman/Director
John Celentano
President/Chief Executive Officer/Director
Timothy Sawyer
Chief Financial Officer/IR Contact Officer
Damian Finio
Secretary
Philip Yachmetz
Independent Director
Carole Ben-Maimon
Independent Director
Bhaskar Chaudhuri
Independent Director
Steven Koehler
Independent Director
Thomas Sabatino
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About TLGT
Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Teligent Inc (NEW JERSEY) stock information, including NASDAQ:TLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLGT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TLGT stock methods without spending real money on the virtual paper trading platform.